Temporal control of sgRNA library activation unlocks large-scale in vivo CRISPR screens
Silvia Fenoglio(Tango Therapeutics (United States)), Teng Teng(Tango Therapeutics (United States)), Ulrich Elling(Institute of Molecular Biotechnology), Tenzing Khendu(Tango Therapeutics (United States)), Shangtao Liu(Tango Therapeutics (United States)), Alborz Bejnood(Broad Institute), Binzhang Shen(Tango Therapeutics (United States)), Samuel R. Meier, Hannah Stowe(Massachusetts General Hospital), Daniel Schramek(Lunenfeld-Tanenbaum Research Institute), Brian B. Haines(Boston Biomedical Research Institute), Annabel Devault(Tango Therapeutics (United States)), Jannik N. Andersen(Tango Therapeutics (United States)), Alan Huang(Tango Therapeutics (United States)), Lauren Grove(Tango Therapeutics (United States)), Ashley H. Choi(Tango Therapeutics (United States)), Minjie Zhang(Tango Therapeutics (United States)), Xuewen Pan(Tango Therapeutics (United States)), Yi Yu(Tango Therapeutics (United States)), James Tepper(Tango Therapeutics (United States)), Hsin‐Jung Wu(Tango Therapeutics (United States)), Erik Wilker(Tango Therapeutics (United States)), Esther C. H. Uijttewaal(Institute of Molecular Biotechnology)
Cited by 0
Related Papers
A Quantitative Proteome Map of the Human Body
|Cell|2020|485
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
|Science|2019|440
New gene functions in megakaryopoiesis and platelet formation
|Nature|2011|424
Emergence of a High-Plasticity Cell State during Lung Cancer Evolution
|Cancer Cell|2020|398